ArticleScientific reports2025
3D endothelial network formation in hydrogels improved by stromal cells and specific growth factors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Engineering Multiscale Vasculature: Biological Principles, Design Constraints, and Advanced Biofabrication Strategies for Functional Vascular Networks.Biomimetics (Basel, Switzerland) · 2026Review
- Prevascularization of electrospun PCL/PLA scaffolds using human adipose-derived stem and endothelial cells enhances vascular integration and host angiogenesis in vivo.Stem cell research & therapy · 2026Article
- Structure-Property-Function Relationships in Stimuli-Responsive Hydrogels for Brain Organoid Vascularization.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The limiting factor in the current state-of-the-art bioengineering of human tissues/organoids in vitro is the lack of functional vasculature that would support growth, metabolic waste removal, and oxygen supply of the formed constructs. The three-dimensional (3D) tissues can be formed by utilization of specific cell types, different hydrogels and scaffolds that provide a physical support, in addition to specific medium composition. Establishment of chemically defined xeno-free conditions is of great interest when keeping in mind the transition from basic research to therapeutic applications. In this study, we present the formation of vascular network of human umbilical vein endothelial cells co-cultured with stromal cells (SCs), human dental pulp SCs or human adipose SCs, in natural hydrogels (Matrigel, GelMA) as well as xeno-free VitroGel hydrogels. As medium composition plays a pivotal role in the successful generation of biological constructs in vitro, we evaluated the potency of specific growth factors (GFs) to induce vascular network formation in 3D hydrogels. We confirmed that vascular endothelial growth factor (VEGF), the most used pro-angiogenic factor, is not mandatory in culture medium for vascular network formation. Rather the endothelial cell (EC) network in co-culture of ECs and SCs can be formed through stimulation of SCs with GFs such as insulin-like growth factor 1 (IGF1), basic fibroblast growth factor (FGF2), and epidermal growth factor (EGF) regardless of serum presence in the medium. Also, we tested completely chemically defined medium that, when used together with xeno-free hydrogel, presents a step forward to application of such tissue constructs in translational regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.